65,437 trials
Coronary Artery Disease
Primary: PRI Levels at 4 Hours — 28.8; 11; 2.8 percentage of platelet reactivity
Pandemic Influenza Disease
Primary: Number of Subjects With at Least One Reactogenicity Sign After Two Doses of the Adjuvanted Pandemic Influenza Vaccine. — 1755; 502; 237; 78 Participants
Depression
Primary: The 17-item Hamilton Depression Scale (HAM-D-17) — -7.4; -4.4; -3.8; -1.7 Scores on a scale — p=.05
Paroxysmal Atrial Fibrillation
Primary: Number of Participants With Successful Pulmonary Vein Isolation — 53 participants
Asthma
Primary: The Mean Change From Baseline to 24 Hour Post-dose (Trough) Forced Expiratory Volume in 1 Second (FEV1) — 0.039; 0.054; 0.124; 0.166 liters
Intubation
Primary: Time to Tracheal Intubation — 21.4; 22.6 seconds
Diabetes · Diabetes Mellitus, Type 1
Primary: Glycosylated Haemoglobin A1c (HbA1c) — 8.00; 7.77; 7.63; 8.15 percentage of total haemoglobin — p=0.001
Prostate Cancer
Primary: Participants' Response in Prostate-Specific Antigen (PSA) Level at Three Months As Compared to Baseline — 16.67; 33.33; 83.33; 66.67 percentage of participants
Malignant Glioma · Glioblastoma · Gliosarcoma
Primary: 6-month Progression-free Survival — 88.8 percentage of participants
Chronic Obstructive Pulmonary Disease
Primary: Number of Participants With Adverse Events, Serious Adverse Events or Death — 102; 33; 16; 6 participants
Allergic Asthma
Primary: Change From Baseline in Total Subepithelial Eosinophils at the End of Week 78 (End of Treatment) — -5.807; -5.890; 1.555; -5.626 cells/mm^2
COPD
Primary: The Mean Change From Baseline to 24 Hour Post-dose (Trough) Forced Expiratory Volume in 1 Second (FEV1) — 0.051; 0.073; 0.076; 0.121 liters
Hepatitis C
Primary: Cmax (Maximum Observed Concentration in Plasma) of MP-424 — 1.62; 1.45; 3.96; 3.06 μg/mL
Influenza
Primary: Geometric Mean Titers After One Dose of Cell Culture-derived or the Egg-derived Influenza Vaccine in Adult Subjects — 12; 15; 16; 14 Titers
Malignant Mesothelioma
Primary: 24 Week Progression Free Survival — 23 percentage of participants